Compare HTHT & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTHT | RVTY |
|---|---|---|
| Founded | 2005 | 1937 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 11.6B |
| IPO Year | 2010 | 1994 |
| Metric | HTHT | RVTY |
|---|---|---|
| Price | $41.81 | $109.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $56.60 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.07% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $7.18 | $6.37 |
| Revenue Next Year | $6.71 | $5.10 |
| P/E Ratio | ★ $30.34 | $308.76 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.42 | $81.22 |
| 52 Week High | $56.53 | $118.30 |
| Indicator | HTHT | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 44.10 | 55.23 |
| Support Level | $40.55 | $108.02 |
| Resistance Level | $45.65 | $117.23 |
| Average True Range (ATR) | 1.03 | 2.91 |
| MACD | 0.21 | -0.52 |
| Stochastic Oscillator | 40.53 | 26.68 |
H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.